Journals / Turkish Journal of Pediatrics / 2020 / Cilt: 62 - Sayı: 2

Clinically isolated syndrome and multiple sclerosis in children: a single center study

Pages
244–251
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Older age at first demyelinating event, the presence of the oligoclonal band in CSF, the number and localization of T2-hyperintense lesion were associated with a tendency for development of MS.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background and objectives.
📊
Key Findings & Data:This was a single center retrospective cohort study of the children with CIS followed-up at Istanbul University Faculty of Medicine, Department of Pediatric Neurology, between 2010 and 2018.
💡
Conclusion & Impact:Older age at first demyelinating event, the presence of the oligoclonal band in CSF, the number and localization of T2-hyperintense lesion were associated with a tendency for development of MS.
🔬Design:Research Article
📍Scope:2010 Verileri
⚙️Variables:Domain Parameters

Özet

Background and objectives. This study was conducted to determine the differences in clinical and radiological features at the first demyelinating event in children with clinically isolated syndrome (CIS) and multiple sclerosis (MS). Methods. This was a single center retrospective cohort study of the children with CIS followed-up at Istanbul University Faculty of Medicine, Department of Pediatric Neurology, between 2010 and 2018. Children with CIS who were assessed at 3, 6, 12 and 24 months following their first identified demyelinating event were included. Demographic data, mode of presentation and the presence of the oligoclonal band in the cerebrospinal fluid (CSF) were abstracted from the medical records. Magnetic resonance imaging of the brain and spinal cord was analyzed for the location, number, size and gadolinium enhancement of the lesions. Results. A total of 51 patients’ data was assessed, 38 patients at a mean age of 12.3 years were enrolled in the study. Twenty-seven children (71%) evolved into clinically definite MS after a mean follow-up of 11 months. Older age at first demyelinating event and the presence of the oligoclonal band in CSF were tended to be more common in patients with MS than patients with CIS (p <0.05). The increased number of T2-hyperintense lesion and the presence of the lesion in periventricular, infratentorial and corpus callosum were associated with a tendency for development of MS (p <0.05). Conclusion. Older age at first demyelinating event, the presence of the oligoclonal band in CSF, the number and localization of T2-hyperintense lesion were associated with a tendency for development of MS.

🔖

Cite This Article

BEKTAŞ, G., ÖZKAN, M. U., YILDIZ, E. P., UZUNHAN, T. A., SENCER, S., AYDINLI, N., ÇALIŞKAN, M., ÖZMEN, M. (2020). Clinically isolated syndrome and multiple sclerosis in children: a single center study. Turkish Journal of Pediatrics, Cilt: 62 - Sayı: 2, 244–251. https://ajindex.com/articles/411845

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Banwell B, Ghezzi A, Bar-Or A, Mikaeloff Y, Tardieu M. Multiple sclerosis in children: Clinical diagnosis, therapeutic strategies, and future directions. Lancet Neurol 2007; 6: 887-902
  2. Chitnis T, Tenembaum S, Banwell B, et al; International Pediatric Multiple Sclerosis Study Group Consensus statement: Evaluation of new and existing therapeutics for pediatric multiple sclerosis. Mult Scler J 2012; 18: 116-127
  3. Miller DH, Chard DT, Ciccarelli O. Clinically isolated syndromes. Lancet Neurol 2012; 11: 157-169
  4. Tintore M, Rovira A, Rio J, et al. Defining high, medium and low impact prognostic factors for developing multiple sclerosis. Brain 2015; 138(Pt 7): 1863-1874
  5. Kappos L, Freedman MS, Polman CH, et al; BENEFIT Study Group Effect of early versus delayed interferon beta-1b treatment on disability after a first clinical event suggestive of multiple sclerosis: A 3-year follow-up analysis of the BENEFIT study. Lancet 2007; 370: 389-397
  6. Sadaka Y, Verhey LH, Shroff MM, et al; Canadian Pediatric Demyelinating Disease Network 2010 McDonald criteria for diagnosing pediatric multiple sclerosis. Ann Neurol 2012; 72: 211-223
  7. Krupp LB, Tardieu M, Amato MP, et al; International Pediatric Multiple Sclerosis Study Group International Pediatric Multiple Sclerosis Study Group criteria for pediatric multiple sclerosis and immune-mediated central nervous system demyelinating disorders: Revisions to the 2007 definitions. Mult Scler J 2013; 19: 1261-1267
  8. Peche SS, Alshekhlee A, Kelly J, Lenox J, Mar S. A long-term follow-up study using IPMSSG criteria in children with CNS demyelination. Pediatr Neurol 2013; 49: 329-334
  9. Krupp LB, Banwell B, Tenembaum S; International Pediatric MS Study Group Consensus definitions proposed for pediatric multiple sclerosis and related disorders. Neurology 2007; 68(16 Suppl 2): S7-S12
  10. Dale RC, Pillai SC. Early relapse risk after a first CNS inflammatory demyelination episode: Examining International consensus definitions. Dev Med Child Neurol 2007; 49: 887-893
  11. Neuteboom RF, Boon M, Catsman Berrevoets CE, et al. Prognostic factors after a first attack of inflammatory CNS demyelination in children. Neurology 2008; 71: 967-973
  12. Alper G, Heyman R, Wang L. Multiple sclerosis and acute disseminated encephalomyelitis diagnosed in children after long-term follow-up: Comparison of presenting features. Dev Med Child Neurol 2009; 51: 480-486
  13. Tantsis EM, Prelog K, Brilot F, Dale RC. Risk of multiple sclerosis